BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 11483331)

  • 1. A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer.
    Song J; Ma S; Sokoll LJ; Eguez RV; Höti N; Zhang H; Mohr P; Dua R; Patil D; May KD; Williams S; Arnold R; Sanda MG; Chan DW; Zhang Z
    Theranostics; 2021; 11(13):6214-6224. PubMed ID: 33995654
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer.
    Deville C; Kamran SC; Morgan SC; Yamoah K; Vapiwala N
    Pract Radiat Oncol; 2024; 14(1):47-56. PubMed ID: 38182303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effective management of biochemical recurrence in patients with prostate cancer.
    McLeod DG
    Rev Urol; 2005; 7 Suppl 5(Suppl 5):S29-36. PubMed ID: 16985881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
    Roach M; Hanks G; Thames H; Schellhammer P; Shipley WU; Sokol GH; Sandler H
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):965-74. PubMed ID: 16798415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer.
    Abramowitz MC; Li T; Buyyounouski MK; Ross E; Uzzo RG; Pollack A; Horwitz EM
    Cancer; 2008 Jan; 112(1):55-60. PubMed ID: 17968996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017.
    Aljubran A; Abusamra A; Alkhateeb S; Alotaibi M; Rabah D; Bazarbashi S; Alkushi H; Al-Mansour M; Alharbi H; Eltijani A; Alghamdi A; Alsharm A; Ahmad I; Murshid E
    Urol Ann; 2018; 10(2):138-145. PubMed ID: 29719323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.
    Abusamra A; Murshid E; Kushi H; Alkhateeb S; Al-Mansour M; Saadeddin A; Rabah D; Bazarbashi S; Alotaibi M; Alghamdi A; Alghamdi K; Alsharm A; Ahmad I
    Urol Ann; 2016; 8(2):123-30. PubMed ID: 27141178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.
    Alkhateeb S; Abusamra A; Rabah D; Alotaibi M; Mahmood R; Almansour M; Murshid E; Alsharm A; Alolayan A; Ahmad I; Alkushi H; Alghamdi A; Bazarbashi S
    Urol Ann; 2014 Oct; 6(4):278-85. PubMed ID: 25371601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saudi Oncology Society clinical management guidelines for prostate cancer.
    Abusamra AJ; Bazarbashi S; Bahader Y; Kushi H; Rabah D; Rabbah D; Al Bogami N; Al Ghamdi K; Al Ghamdi A; Balaraj K; Seyam R; Al Otaibi M; Al Saeed E
    Urol Ann; 2011 Mar; 3 Suppl(Suppl):S10-6. PubMed ID: 21673847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Locally recurrent prostate cancer following radiation therapy: radical salvage prostatectomy].
    Heidenreich A; Thüer D; Pfister D
    Urologe A; 2010 Jun; 49(6):734-40. PubMed ID: 20237908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.
    Ray ME; Bae K; Hussain MH; Hanks GE; Shipley WU; Sandler HM
    J Natl Cancer Inst; 2009 Feb; 101(4):228-36. PubMed ID: 19211454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radical salvage prostatectomy : Treatment of local recurrence of prostate cancer after radiotherapy].
    Heidenreich A; Semrau R; Thüer D; Pfister D
    Urologe A; 2008 Nov; 47(11):1441-6. PubMed ID: 18806991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Salvage radical prostatectomy].
    Hautmann RE
    Urologe A; 2006 Oct; 45(10):1260-5. PubMed ID: 16983529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stochastic model for PSA levels: behavior of solutions and population statistics.
    Belík P; Dayananda PW; Kemper JT; Shvartsman MM
    J Math Biol; 2006 Sep; 53(3):437-63. PubMed ID: 16832692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy.
    Kuban DA; Thames HD; Levy LB
    World J Urol; 2003 Sep; 21(4):253-64. PubMed ID: 12923658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitions of biochemical failure in prostate cancer following radiation therapy.
    Taylor JM; Griffith KA; Sandler HM
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1212-9. PubMed ID: 11483331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.
    Thames H; Kuban D; Levy L; Horwitz EM; Kupelian P; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):929-43. PubMed ID: 14575823
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.